Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00099450 | Study of the Tolerability, Pharmacokinetics, and Pharmacodynamics of INS50589 Intravenous Infusion in Healthy Volunteers | PHASE1 | COMPLETED | 48 | — | — | Dec 1, 2004 | Mar 1, 2005 | Jan 21, 2015 | 1 | United States |
| Name | Type | Description |
|---|---|---|
| INS50589 Intravenous Infusion | DRUG | - |
Inclusion Criteria: * Have body mass index (BMI) between 18.5 kg/m2 and 35 kg/m2 and body weight no greater than 120 kg. * If female, must not be pregnant or lactating, and if of childbearing potential or sexually active, must use acceptable method of birth control. Exclusion Criteria: * Have cli...